
Cell Therapy Manufacturing Market Set to Hit USD 23.2 Billion by 2036
The global cell therapy manufacturing market is projected to reach USD 23.2 billion by 2036, rising from its current valuation of USD 6.2 billion. Driven by a 14.1% annual growth rate, the sector is shifting from clinical-stage development to high-volume commercial production of advanced regenerative medicines.

























